CellBion eyes global expansion in radiopharmaceuticals after Kosdaq IPO
CellBion, a Korean developer of radioisotope-based cancer therapeutics, announced its plans for global growth following its recent Kosdaq listing. At a press conference on Wednesday, CEO Kim Kweon outlined the company's vision to develop new …